NBTY Reports Fourth Quarter and Year-End Results BOHEMIA, N.Y.,
Nov. 10 /PRNewswire-FirstCall/ -- NBTY, Inc.
(http://www.nbty.com/), a leading manufacturer and marketer of
nutritional supplements today announced results for the fiscal
fourth quarter and fiscal year ended September 30, 2003. For the
fiscal fourth quarter ended September 30, 2003, sales increased 49%
to $365 million, compared to $245 million for the fiscal fourth
quarter ended September 30, 2002. Net income for the fiscal fourth
quarter 2003 was $14 million, or $0.20 per diluted share, compared
to net income of $29 million, or $0.43 per diluted share, for the
comparable period last year. Results for the fiscal fourth quarter
2003 included certain non-recurring charges totaling $10 million,
pre-tax, that decreased net earnings by $0.11 per diluted share.
Included in these one-time charges was a write-off of $7 million
relating to the Company's investment in high yield bonds purchased
in anticipation of an acquisition which NBTY determined not to
pursue because of ephedra exposure, among other things. The balance
of these charges were attributed to various items, including: the
discontinuation of the Company's network marketing operations; fees
and expenses associated with another acquisition which the Company
chose not to consummate principally because of litigation exposure;
and the closure of the Company's facilities in Murphysboro,
Illinois and Thornton, Colorado that occurred in conjunction with
integrating the operations of Rexall Sundown. NBTY acquired Rexall
on July 25, 2003. Rexall's sales from that date until September 30,
2003 were $73 million. Without Rexall sales, NBTY sales would have
increased 19% in the fiscal fourth quarter 2003. For fiscal 2003,
sales increased 24% to $1.2 billion compared to $964 million for
fiscal 2002. Net income for fiscal 2003 was $80 million, or $1.16
per diluted share, compared to net income of $96 million, or $1.41
per diluted share, for fiscal 2002. Results for fiscal year 2003
included the aforementioned non-recurring charges totaling $10
million, pre-tax, that decreased net earnings by $0.11 per diluted
share. Without Rexall sales, NBTY sales would have increased 16%
for fiscal 2003. At September 30, 2003, the Company's total assets
were $1.2 billion and its working capital was $312 million,
compared with total assets of $730 million and working capital of
$186 million at September 30, 2002. OPERATIONS FOR THE FISCAL
FOURTH QUARTER ENDED SEPTEMBER 30, 2003 For the fiscal fourth
quarter 2003, sales for the wholesale division increased $90
million to $164 million, an increase of 122%, compared to $74
million for the fiscal fourth quarter 2002. The increase in 2003
includes $73 million of Rexall sales with EBITDA of $10 million.
Without Rexall sales, the wholesale division's sales would have
increased by 23% for the fiscal fourth quarter 2003. The Rexall
acquisition added numerous well-known brands to the Company's
wholesale operation. These brands include Rexall(R), Sundown(R),
Osteo Bi-Flex(R), CarbSolutions(TM), MET-Rx(R) and WORLDWIDE Sports
Nutrition(R). With this acquisition, NBTY reinforces its dominant
position in the wholesale sector. The integration of the
acquisition is on schedule. The Company continues to leverage
valuable consumer sales information it receives from its Vitamin
World and direct response/e-commerce operations. This information
is monitored on a daily basis and used as a planning tool in the
introduction of new products to our wholesale customers. The
success of this strategy is demonstrated by the acceptance of our
new products by the mass-market retailers and their customers. NBTY
remains focused on increasing market share in the wholesale channel
and expanding its presence in the nutritional supplement
marketplace. Vitamin World sales for the fiscal fourth quarter 2003
were $54 million, compared to $52 million for the comparable prior
period. Vitamin World's same store sales for the fiscal fourth
quarter 2003 increased 4%. Although Vitamin World generated EBITDA
of $2 million for the fiscal fourth quarter 2003, Vitamin World
operations recorded a loss of $2 million. Included in this loss is
an asset impairment charge, in the form of accelerated
depreciation, for certain unprofitable stores. Vitamin World
currently has 533 stores in operation nationwide. During fiscal
2003, the Company closed twenty Vitamin World stores and added nine
new stores. Sales from NBTY's European retail operations for the
fiscal fourth quarter 2003 increased 27% to $95 million from $74
million for the fiscal fourth quarter 2002. This 27% increase
includes sales generated by 50 GNC stores in the UK and 65 DeTuinen
stores in the Netherlands acquired earlier this fiscal year. GNC
(UK) and DeTuinen each generated sales of $9 million in the fiscal
fourth quarter 2003. Although GNC (UK) was marginally profitable,
DeTuinen incurred a $500,000 loss for the fiscal fourth quarter
2003. Holland & Barrett's same store sales for the fiscal
fourth quarter 2003 increased 2% with foreign exchange. Holland
& Barrett continues to be a leader in the UK and Ireland. The
Company's European division currently operates 589 stores in the
UK, Ireland and the Netherlands. Revenues from Puritan's Pride
direct response/e-commerce operations for the fiscal fourth quarter
2003 increased 16% to $52 million from $45 million for the fiscal
fourth quarter 2002. Online sales, which increased more than 50%
for the fiscal fourth quarter 2003, comprised 21% of sales for the
fiscal fourth quarter 2003. The increase in sales reflects the
continued success of investments in advertising, sales promotions
and faster product delivery to customers. OPERATIONS FOR THE FISCAL
YEAR ENDED SEPTEMBER 30, 2003 Sales by segment for fiscal 2003 were
as follows: wholesale sales were $417 million, an increase of 43%;
Vitamin World sales were $212 million, an increase of 7%; European
retail operation sales were $364 million, an increase of 25%; and
Puritan's Pride sales were $200 million, an increase of 9%.
Excluding $73 million of Rexall sales, wholesale sales would have
increased by 18% for fiscal 2003. NBTY Chairman and CEO, Scott
Rudolph, said: "The fourth quarter reflected a wide array of
transitional issues which we anticipate will be resolved in fiscal
2004. The integration of Rexall is on schedule and has already
contributed significantly to our revenue growth. The Rexall
acquisition is indicative of our commitment to the wholesale
segment, and we anticipate continued growth in revenue and market
share for NBTY." ABOUT NBTY NBTY is a leading vertically integrated
manufacturer and distributor of a broad line of high-quality,
value-priced nutritional supplements in the United States and
throughout the world. The Company markets approximately 1,500
products under several brands, including Nature's Bounty(R),
Vitamin World(R), Puritan's Pride(R), Holland & Barrett(R),
Rexall(R), Sundown(R), MET-Rx(R), WORLDWIDE Sports Nutrition(R),
American Health(R), GNC (UK)(R) and DeTuinen(R). This release
contains certain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 with respect
to our financial condition, results of operations and business. All
of these forward-looking statements, which can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy which, although believed to be reasonable,
are inherently uncertain. Factors which may materially affect such
forward-looking statements include: (i) slow or negative growth in
the nutritional supplement industry; (ii) interruption of business
or negative impact on sales and earnings due to acts of war,
terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance; (xiv) exposure to and expense of defending and
resolving, product liability claims and other litigation; (xv) the
ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manage its retail, wholesale,
manufacturing and other operations efficiently; (xvii) consumer
acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases on its retail locations; (xix) inability of NBTY's
retail stores to attain or maintain profitability; (xx) the absence
of clinical trials for many of NBTY's products; (xxi) sales and
earnings volatility and/or trends; (xxii) the efficacy of NBTY's
Internet and on-line sales and marketing; (xxiii) fluctuations in
foreign currencies, including the British Pound; (xxiv)
import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in
opening, new retail locations; (xxvi) introduction of new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world, and more
particularly the Food Supplements Directive and the Traditional
Herbal Medicinal Products Directive in Europe; (xxvii) the mix of
NBTY's products and the profit margins thereon; (xxviii) the
availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; and (xxx) other factors beyond NBTY's control. Readers
are cautioned not to place undue reliance on forward-looking
statements. NBTY cannot guarantee future results, trends, events,
levels of activity, performance or achievements. NBTY does not
undertake and specifically declines any obligation to update,
republish or revise forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrences
of unanticipated events. NBTY, INC. and SUBSIDIARIES CONDENSED
CONSOLIDATED STATEMENTS OF INCOME (Dollars and shares in thousands,
except per share amounts) For the three months ended September 30,
2003 2002 Net sales $364,847 $245,461 Cost and expenses: Cost of
sales 182,249 107,805 Discontinued product charge (1,500) Catalog
printing, postage and promotion 20,439 13,561 Selling, general and
administrative 132,281 90,568 Litigation recovery of raw material
costs (836) 333,469 211,098 Income from operations 31,378 34,363
Other (expense): Interest (5,674) (3,912) Investment write down
(6,659) Miscellaneous, net (112) (765) (12,445) (4,677) Income
before income taxes 18,933 29,686 Provision for income taxes 4,951
338 Net income $ 13,982 $ 29,348 Net income per share: Basic $ 0.21
$ 0.44 Diluted $ 0.20 $ 0.43 Weighted average common shares
outstanding: Basic 66,547 66,122 Diluted 68,796 67,986 NBTY, INC.
and SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars and shares in thousands, except per share amounts) For the
fiscal years ended September 30, 2003 2002 Net sales $1,192,548
$964,083 Cost and expenses: Cost of sales 554,804 433,611
Discontinued product charge 4,500 Catalog printing, postage and
promotion 66,455 47,846 Selling, general and administrative 435,748
348,334 Litigation recovery of raw material costs (21,354)
1,061,507 808,437 Income from operations 131,041 155,646 Other
income (expense): Interest (17,384) (18,499) Investment write down
(6,659) Miscellaneous, net 5,424 1,560 (18,619) (16,939) Income
before income taxes 112,422 138,707 Provision for income taxes
32,738 42,916 Net income $79,684 $95,791 Net income per share:
Basic $1.20 $1.45 Diluted $1.16 $1.41 Weighted average common
shares outstanding: Basic 66,452 65,952 Diluted 68,538 67,829 SALES
(Thousands) THREE MONTHS FISCAL YEARS ENDED ENDED SEPTEMBER 30,
SEPTEMBER 30, % % 2003 2002 Increase 2003 2002 Increase Wholesale
$163,721 $73,610 122% $416,627 $291,287 43% US Retail/ Vitamin
World 54,138 52,255 4% 212,380 198,602 7% European Retail/ Holland
& Barrett/ 94,694 74,397 27% 363,597 290,881 25% Direct
Response/ Puritan's Pride 52,294 45,199 16% 199,944 183,313 9%
Total $364,847 $245,461 49% $1,192,548 $964,083 24% GROSS PROFIT
PERCENTAGES THREE MONTHS ENDED FISCAL YEARS ENDED SEPTEMBER 30,
SEPTEMBER 30, % % 2003 2002 Increase 2003 2002 Increase Wholesale
39% 44% -5% 40% 41% -1% US Retail/Vitamin World 60% 59% 1% 60% 59%
1% European Retail/ Holland & Barrett/GNC 59% 64% -5% 61% 63%
-2% Direct Response/ Puritan's Pride 60% 60% 0% 62% 61% 1% Total
(without discontinued product charge) 50% 56% -6% 54% 55% -1%
Discontinued product charge 1% 1% -1% -1% Total 51% 56% -5% 53% 55%
-2% INCOME FROM OPERATIONS BY SEGMENT (Thousands) THREE MONTHS
ENDED FISCAL YEARS ENDED SEPTEMBER 30, SEPTEMBER 30, 2003 2002 2003
2002 Wholesale $23,149 $15,986 $76,933 $60,197 US Retail/Vitamin
World (1,983) 59 (1,643) (4,975) European Retail/ Holland &
Barrett/GNC 18,802 20,380 83,345 79,421 Direct Response/Puritan's
Pride 17,440 14,333 62,184 66,273 Segment Results 57,408 50,758
220,819 200,916 Corporate Expenses (27,530) (17,231) (85,278)
(66,624) Discontinued Product Charge 1,500 (4,500) Litigation
Recovery of Raw Material Costs 836 21,354 Income from Operations
$31,378 $34,363 $131,041 $155,646 Non-recurring charges included in
operations: Provision for plant closures 2,645 Unsuccessful
acquisition costs 1,000 Total non-recurring charges included in
operations 3,645 -- Income from operations excluding non-recurring
charges $35,023 $34,363 NBTY, INC. and SUBSIDIARIES CONDENSED
CONSOLIDATED BALANCE SHEETS ASSETS (Dollars and shares in
thousands) September 30, September 30, 2003 2002 Current assets:
Cash and cash equivalents $49,349 $26,229 Investments in bonds
1,583 8,194 Accounts receivable, less allowance for doubtful
accounts of $10,463 at September 30, 2003 and $4,194 at September
30, 2002 89,430 36,825 Inventories 314,091 204,402 Deferred income
taxes 37,021 11,206 Prepaid expenses and other current assets
44,736 24,691 Total current assets 536,210 311,547 Property, plant
and equipment, net 298,344 216,245 Goodwill 213,362 144,999
Intangible assets, net 137,469 48,413 Other assets 16,423 8,936
Total assets $1,201,808 $730,140 NBTY, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS LIABILITIES AND STOCKHOLDERS'
EQUITY (Dollars and shares in thousands) September 30, September
30, 2003 2002 Current liabilities: Current portion of long-term
debt and capital lease obligations $12,841 $23,044 Accounts payable
87,039 48,616 Accrued expenses and other current liabilities
123,956 54,177 Total current liabilities 223,836 125,837 Long-term
debt 413,989 163,874 Deferred income taxes 40,213 16,928 Other
liabilities 10,872 4,244 Total liabilities 688,910 310,883
Commitments and contingencies Stockholders' equity: Common stock,
$0.008 par; authorized 175,000 shares; issued and outstanding
66,620 shares at September 30, 2003 and 66,322 shares at September
30, 2002 533 529 Capital in excess of par 130,208 126,283 Retained
earnings 367,552 287,868 498,293 414,680 Accumulated other
comprehensive income 14,605 4,577 Total stockholders' equity
512,898 419,257 Total liabilities and stockholders' equity
$1,201,808 $730,140 NBTY, INC. AND SUBSIDIARIES CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) For
the fiscal years ended September 30, 2003 2002 Cash flows from
operating activities: Net income $79,684 $95,791 Adjustments to
reconcile net income to net cash provided by operating activities:
(Gain)/loss on disposal/sale of property, plant and equipment (711)
102 Depreciation and amortization 46,884 42,192 Foreign currency
exchange rate (gain) loss (334) 1,556 Amortization of deferred
financing costs 1,003 782 Amortization of bond discount 124 124
Investment write down 6,659 Allowance for doubtful accounts (2,906)
972 Deferred income taxes 6,033 (5,829) Compensation expense for
ESOP 1,710 Tax benefit from exercise of stock options 1,072 1,815
Changes in assets and liabilities, net of acquisitions: Accounts
receivable (1,466) (7,011) Inventories (23,879) (14,277) Prepaid
expenses and other current assets (15,855) (3,432) Other assets 616
(586) Accounts payable (2,773) (3,442) Accrued expenses and other
liabilities 15,671 (3,670) Net cash provided by operating
activities 111,532 105,087 Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired (289,676) (7,702)
Purchase of property, plant and equipment (37,510) (21,489)
Proceeds from sale of property, plant, and equipment 1,498 1,004
Proceeds from sale of intangibles 53 Purchase of short term
investments (8,242) Release of cash held in escrow 2,403 4,600 Net
cash used in investing activities (323,285) (31,776) Cash flows
from financing activities: Principal payments under long-term debt
agreements and capital leases (35,212) (85,353) Proceeds from
borrowings under long term debt agreements 275,000 Payments for
debt issuance costs (7,500) Proceeds from stock options exercised
1,147 1,899 Net cash provided by (used in) financing activities
233,435 (83,454) Effect of exchange rate changes on cash and cash
equivalents 1,438 1,938 Net increase (decrease) in cash and cash
equivalents 23,120 (8,205) Cash and cash equivalents at beginning
of year 26,229 34,434 Cash and cash equivalents at end of year
$49,349 $26,229 Supplemental disclosure of cash flow information:
Cash paid during the period for interest $17,709 $18,513 Cash paid
during the period for income taxes $34,698 $55,101 DATASOURCE:
NBTY, Inc. CONTACT: Harvey Kamil, President and CFO of NBTY, Inc.,
+1-631-244-2020; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, , for NBTY, Inc. Web site: http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
N B T Y (NYSE:NTY)
Historical Stock Chart
From Jul 2023 to Jul 2024